The March edition of the Transplant Trial Watch is now available via our website and the Trial Watch App. This month’s trials include the effect of Omega-3 on hepatic regeneration after live liver donation, prophylactic azithromycin after lung transplantation, and the consequences of complete tacrolimus withdrawal in renal transplant recipients.
The CET team would like to wish everyone a Happy New Year! A new year means that this month’s Transplant Trial Watch is now out. New studies include a systematic review of outcomes in obese kidney transplant recipients, CNI and steroid-free immunosuppression in renal transplantation, and a direct mail campaign to improve donor registration.
The July edition of the transplant trial watch is now available on our website and via the app for iPhone, iPad and Android. This months trials include computer-guided tacrolimus dosing, radial versus femoral cannulation for cardiac transplantation and Sorafenib in liver transplant candidates with HCC.
A recent article in the BMJ by Abraha et al, using large amounts of data from RCTs, has shown that deviation from intention-to-treat analysis (ITT) can lead to apparently larger treatment effects. When compared to standard intention-to-treat analysis there was a significant difference in the apparent treatment effect. When a deviation from ITT was compared […]
The May 2014 edition of the transplant trial watch is now available on the CET site, as well as our mobile apps for iPhone, iPad and Android. This month, studies include a systematic review of hypothermic machine preservation in renal transplantation, metallic stents for biliary strictures following liver transplantation and tablet computer-based patient education.
The March 2014 edition of the Transplant Trial Watch is now available online and via the CET’s app for iPhone, iPad and Android. This month, trials include the effects of cyclosporin A and tacrolimus on fibrosis following liver transplantation for hepatitis C, intravesical vs. extravesical ureteroneocystostomy in renal transplantation and the use of sitagliptin in […]
There was an interesting editorial by Richard Smith and Drummond Rennie in the BMJ recently. The editorial is based on two interviews of pioneers in this field by Richard Smith, the former editor of the BMJ. In the first oral history he interviews Iain Chalmers, Muir Gray and David Sackett. They said that authors from a […]
The deadline to register for the Evidence in Transplantation (EVIT) course has been extended and you can now apply for one of the last few places of this highly rated course. EVIT last call The EVIT course is organised in collaboration with ESOT and will run on 21 and 22 March 2014 at the Royal College […]
The January 2014 edition of the Transplant Trial Watch is now available. This month’s new trials include Letermovir for post-transplant CMV infection, a suggestion that Alemtuzumab increases de-novo DSA production and a phase I study of a novel TLR-2 monoclonal antibody. You can read the CET’s summaries of these trials (and more) on the CET […]